“whitehead-institute” Archives

in
Entry Author Date Location
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology 11/14/19 Boston
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further 09/23/19 Boston
CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech 05/31/18 Boston
Still Years From Clinic, Navitor Gets $33M And More Pharma Friends 12/18/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
What’s Hot in Boston Biotech? Here’s the Agenda 03/26/15 Boston
Find Out “What’s Hot in Boston Biotech” on April 8 02/05/15 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
East Coast Biotech Roundup: Bristol-Myers, Syros, On-Q-ity, Ziopharm 04/12/13 Boston
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells 11/16/10 Boston
Fate Therapeutics Expands its Stem Cell Empire Into Canada 04/08/10 National
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key 10/18/09 National
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology 09/30/09 National
Immuneering, Led by Young CEO and Mentor, Aims to Pick Which Cancer Drugs Should Work 07/07/09 Boston
$50M Pumped Into Ironwood Coffers 10/01/08 Boston
Page 1 of 1